Newly synthesized phenanthroimidazole derivatives L082 as a safe anti-tumor and anti-injury inflammation bifunctional compound
Copyright © 2020 Elsevier B.V. All rights reserved..
Chemotherapy drugs exerts beneficial antitumor activity before and after cancer surgery. Post-injury complications are a potential hazard after surgical tumor resection. Inflammation caused by surgical stress is known to promote the progression of post-injury complications. Recent studies have found that chemotherapy drugs can promote post-injury inflammatory response, leading to increased post-injury complications. Imidazole derivatives have effective anticancer activity. However, the impact of post-operative inflammation caused by imidazole derivatives is unclear. In this study, two novel phenanthroimidazole derivatives (L082 and L142) were synthesized and characterized. These compounds showed significant inhibitory effects on different tumor cells. The compound L082 also inhibited liver cancer in vivo. In addition, L082 played a significant role in inhibiting the accumulation of inflammatory cells and promoting the elimination of inflammatory cells at the incision, which may be related to inhibiting the production of ROS and NO in oxidative and nitric stress. These results suggest that L082 can be used as a bifunctional drug to suppress tumors and reduce post-injury inflammation complications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:889 |
---|---|
Enthalten in: |
European journal of pharmacology - 889(2020) vom: 15. Dez., Seite 173571 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lai, Shi-Feng [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 14.05.2021 Date Revised 14.05.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ejphar.2020.173571 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316018341 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316018341 | ||
003 | DE-627 | ||
005 | 20231225160153.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ejphar.2020.173571 |2 doi | |
028 | 5 | 2 | |a pubmed24n1053.xml |
035 | |a (DE-627)NLM316018341 | ||
035 | |a (NLM)33031798 | ||
035 | |a (PII)S0014-2999(20)30663-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lai, Shi-Feng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Newly synthesized phenanthroimidazole derivatives L082 as a safe anti-tumor and anti-injury inflammation bifunctional compound |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.05.2021 | ||
500 | |a Date Revised 14.05.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier B.V. All rights reserved. | ||
520 | |a Chemotherapy drugs exerts beneficial antitumor activity before and after cancer surgery. Post-injury complications are a potential hazard after surgical tumor resection. Inflammation caused by surgical stress is known to promote the progression of post-injury complications. Recent studies have found that chemotherapy drugs can promote post-injury inflammatory response, leading to increased post-injury complications. Imidazole derivatives have effective anticancer activity. However, the impact of post-operative inflammation caused by imidazole derivatives is unclear. In this study, two novel phenanthroimidazole derivatives (L082 and L142) were synthesized and characterized. These compounds showed significant inhibitory effects on different tumor cells. The compound L082 also inhibited liver cancer in vivo. In addition, L082 played a significant role in inhibiting the accumulation of inflammatory cells and promoting the elimination of inflammatory cells at the incision, which may be related to inhibiting the production of ROS and NO in oxidative and nitric stress. These results suggest that L082 can be used as a bifunctional drug to suppress tumors and reduce post-injury inflammation complications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Anti-post-injury inflammatory complication | |
650 | 4 | |a Anti-tumor | |
650 | 4 | |a Phenanthroimidazole derivatives | |
650 | 4 | |a Zebrafish | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Phenanthrenes |2 NLM | |
650 | 7 | |a 2-aminophenanthroimidazole |2 NLM | |
650 | 7 | |a 37052-13-4 |2 NLM | |
700 | 1 | |a Liu, Ruo-Tong |e verfasserin |4 aut | |
700 | 1 | |a Peng, Wen-Hui |e verfasserin |4 aut | |
700 | 1 | |a Huang, Xiao-Ting |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xi-Cheng |e verfasserin |4 aut | |
700 | 1 | |a Qian, Jia-Yi |e verfasserin |4 aut | |
700 | 1 | |a Mei, Wen-Jie |e verfasserin |4 aut | |
700 | 1 | |a Cheng, Meng-Ya |e verfasserin |4 aut | |
700 | 1 | |a Wang, Teng |e verfasserin |4 aut | |
700 | 1 | |a Wang, Bao-Guo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of pharmacology |d 1967 |g 889(2020) vom: 15. Dez., Seite 173571 |w (DE-627)NLM000029769 |x 1879-0712 |7 nnns |
773 | 1 | 8 | |g volume:889 |g year:2020 |g day:15 |g month:12 |g pages:173571 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejphar.2020.173571 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 889 |j 2020 |b 15 |c 12 |h 173571 |